TWD 62.7
(2.96%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -144.81 Million TWD | 10.05% |
2022 | -161 Million TWD | -7.05% |
2021 | -150.39 Million TWD | 13.28% |
2020 | -173.41 Million TWD | 36.2% |
2019 | -271.79 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -48.16 Million TWD | -8.79% |
2024 Q2 | -21.88 Million TWD | 54.56% |
2023 Q4 | -44.27 Million TWD | -63.26% |
2023 FY | -144.81 Million TWD | 10.05% |
2023 Q3 | -27.12 Million TWD | -9.75% |
2023 Q2 | -24.71 Million TWD | 49.27% |
2023 Q1 | -48.7 Million TWD | -6.56% |
2022 Q4 | -45.71 Million TWD | 0.0% |
2022 FY | -161 Million TWD | -7.05% |
2021 FY | -150.39 Million TWD | 13.28% |
2020 FY | -173.41 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Allied Biotech Corporation | 97.41 Million TWD | 248.665% |
GeneFerm Biotechnology Co., Ltd. | 124.62 Million TWD | 216.207% |
TTY Biopharm Company Limited | 1.12 Billion TWD | 112.833% |
Synmosa Biopharma Corporation | 594.83 Million TWD | 124.346% |
Orient EuroPharma Co., Ltd. | 143.94 Million TWD | 200.608% |
Center Laboratories, Inc. | -995.42 Million TWD | 85.452% |
Tien Liang BioTech Co., Ltd. | 17.73 Million TWD | 916.704% |
Orient Pharma Co., Ltd. | 22.28 Million TWD | 749.758% |
InnoPharmax Inc. | -70.83 Million TWD | -104.456% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 79.7 Million TWD | 281.704% |
Excelsior Biopharma Inc. | -91.01 Million TWD | -59.121% |
DV Biomed Co., Ltd. | 162.91 Million TWD | 188.894% |
Foresee Pharmaceuticals Co., Ltd. | -1.03 Billion TWD | 86.026% |
Handa Pharmaceuticals, Inc. | 726.88 Million TWD | 119.923% |
UniPharma Co., Ltd. | -21.81 Million TWD | -563.907% |
Anxo Pharmaceutical Co., Ltd. | 21.86 Million TWD | 762.449% |
Alar Pharmaceuticals Inc. | 382.61 Million TWD | 137.849% |
Winston Medical Supply Co., Ltd. | 158.75 Million TWD | 191.221% |
Mercury Biopharmaceutical Corporation | -43.81 Million TWD | -230.514% |
Bioray Biotech Co., Ltd | -11.55 Million TWD | -1152.859% |
TSH Biopharm Corporation Limited | 61.98 Million TWD | 333.619% |